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Methicillin-susceptible Staphylococcus aureus (MSSA) can arise from methicillin-resistant S. aureus (MRSA)
following partial or complete excision of staphylococcal cassette chromosome mec (SCCmec). This study
investigated whether multiresistant MSSA isolates from Irish hospitals, where MRSA has been endemic for
decades, harbor SCCmec DNA. Twenty-five multiresistant MSSA isolates recovered between 2002 and 2006
were tested for SCCmec DNA by PCR and were genotyped by multilocus sequence typing and spa typing. All
isolates lacked mecA. Three isolates (12%) harbored SCCmec DNA; two of these (genotype ST8/t190) harbored
a 26-kb SCCmec IID (II.3.1.2) remnant that lacked part of mecI and all of mecR1, mecA, and IS431; the third
isolate (ST8/t3209) harbored the SCCmec region from dcs to orfX. All three isolates were detected as MRSA
using the BD GeneOhm and Cepheid’s Xpert MRSA real-time PCR assays. Six isolates (ST8/t190, n ⴝ 4;
ST5/t088, n ⴝ 2), including both isolates with the SCCmec IID remnant, harbored ccrAB4 with 100% identity
to ccrAB4 from the Staphylococcus epidermidis composite island SCC-CI. This ccrAB4 gene was also identified
in 23 MRSA isolates representative of ST8/t190-MRSA with variant SCCmec II subtypes IIA to IIE, which
predominated previously in Irish hospitals. ccrAB4 was located 5,549 bp upstream of the left SCCmec junction
in both the MRSA and MSSA isolates with SCCmec elements and remnants and 5,549 bp upstream of orfX in
the four MSSA isolates with ccrAB4 only on an SCC-CI homologous region. This is the first description of a
large SCCmec remnant with ccr and partial mec genes in MSSA and of the S. epidermidis SCC-CI and ccrAB4
genes in S. aureus.

susceptible S. aureus (MSSA) upon site-specific integration of
SCCmec into the orfX locus in the chromosome of a susceptible isolate. SCCmec consists of three regions: a mec complex
carrying mecA and, if present, its regulatory genes mecI and
mecR1, a ccr complex carrying cassette chromosome recombinase (ccr) genes, and a series of variable “junkyard” or J
regions (30). To date, six types of SCCmec have been recognized in S. aureus, with three additional new types and numerous variants also recently being reported (14, 21, 48, 61).
SCCmec has been found in other staphylococcal species, including S. epidermidis, S. haemolyticus, S. hominis, and S. warneri (19, 20, 62, 65). At least five non-mec-containing SCC
elements have also been described, two in MSSA (SCCcap1
and SCC476), one in S. epidermidis (SCC-CI with SCCpbp4),
and one in S. hominis (SCC12263) (31, 35, 41). The complexity and
evolutionary history of SCC demonstrates the versatility with
which S. aureus can acquire, disseminate, modify, and delete
resistance determinants (14, 34, 43, 44).
MRSA has been endemic in Irish hospitals for many years.
In 2003, the rate of methicillin resistance among S. aureus
isolates recovered from blood culture was 42%, placing Ireland
among the countries with the highest rates of MRSA in Europe

Staphylococcus aureus is a significant human pathogen that
can cause a wide variety of diseases, due in part to its ability to
acquire and express an extensive array of virulence factors and
antimicrobial resistance determinants. Mobile genetic elements are involved in the dissemination of virulence and resistance genes in S. aureus and include plasmids, bacteriophages, pathogenicity islands, transposons, and chromosomal
cassettes (3, 4, 18, 24, 26, 30, 38, 45, 63, 64).
Following the introduction of methicillin into clinical use,
methicillin-resistant S. aureus (MRSA) has emerged as a major
nosocomial problem worldwide. Today MRSA continues to be
a significant burden in hospitals but has also emerged as a
problem in the community (22). Methicillin resistance in S.
aureus is encoded by the mecA gene, which is located within a
mobile staphylococcal cassette chromosome (SCC) element
known as SCCmec (22). MRSA can emerge from methicillin* Corresponding author. Mailing address: Microbiology Research
Unit, Division of Oral Biosciences, School of Dental Science and
Dublin Dental Hospital, University of Dublin, Trinity College Dublin,
Dublin 2, Ireland. Phone: 353-1-6127276. Fax: 353-1-6127295. E-mail:
david.coleman@dental.tcd.ie.
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(42). Monitoring of the epidemiological types that comprise
the Irish MRSA population by antibiogram-resistogram (AR)
typing and chromosomal DNA macrorestriction analysis using
pulsed-field gel electrophoresis (PFGE) has shown that the
MRSA population changed between 1999 and 2003, with a
non-multiantibiotic-resistant strain exhibiting the AR type and
PFGE group (AR-PFG) type 06-01 (ST22-MRSA-IV), displacing the previously predominant multiantibiotic-resistant
strains AR-PFG type 13-00 or 14-00 (13-00 and 14-00 isolates
exhibit the genotype ST8-MRSA-II) (54). In the present study,
multiantibiotic resistance is defined as resistance to two or
more classes of non-beta-lactam antibiotics (11). Isolates exhibiting AR-PFG 13-00 or 14-00 are resistant to the aminoglycoside antimicrobial agent gentamicin and accounted for 50%
of the MRSA population in 1999 (55). Although largely replaced by AR-PFG 06-01 in acutely ill patients with invasive
disease (for example, among patients with bacteremia), older
strains may persist among chronically ill patients and in longstay care units. The importance of the long-term persistence of
MRSA in patients with osteomyelitis has been noted in both
human and veterinary medicine (1, 58).
In some strains of MRSA or in some specific circumstances
(e.g., during the absence of antibiotic selective pressure),
SCCmec may be unstable and can be excised (8, 11). Furthermore, exposure of MRSA to the glycopeptide antibiotic vancomycin can also lead to mecA excision, and Noto et al. (43)
reported that S. aureus may compensate for the fitness cost
incurred by developing reduced susceptibility to vancomycin by
deleting all or a portion of SCCmec. It has also been reported
that when SCCmec is excised from multiantibiotic-resistant
MRSA, the resulting MSSA strain may carry a larger number
of resistance determinants than would usually be found in
MSSA (11).
While there are vast amounts of data in the literature concerning the structure of the numerous SCCmec elements that
have been identified in MRSA, there is only very limited information on segments of SCCmec in multiresistant MSSA
isolates following partial excision or integration of SCCmec (6,
11, 13, 25, 57). The purpose of the present study was to investigate whether multiresistant MSSA isolates recovered from
patients in Irish hospitals carried segments of SCCmec and to
compare their genotypes to each other’s and to those of multiresistant MRSA isolates previously recovered in Ireland using multilocus sequence typing (MLST) and spa typing. In
selecting the MSSA isolates for analysis, gentamicin resistance
was used as a surrogate marker for multiantibiotic resistance
because evidence from a previous study indicated that in Ireland, multiantibiotic-resistant MRSA strains were also gentamicin resistant (53). In the present study, isolates carrying
SCCmec- and/or SCC-specific DNA were subsequently tested
using two commercially available real-time PCR assays for the
rapid detection of MRSA from clinical specimens. The assays
chosen were the BD GeneOhm MRSA and Cepheid’s Xpert
MRSA assays, both of which target the region from SCCmec to
orfX.
MATERIALS AND METHODS
Isolates. All gentamicin-resistant MSSA (GrMSSA) isolates recovered between 2004 and 2006 (n ⫽ 19) from patients attending a large (936-bed) tertiaryreferral Dublin hospital (hospital 1), together with GrMSSA isolates (n ⫽ 6)
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from five other Irish hospitals, referred to the Irish National MRSA Reference
Laboratory for investigation of methicillin resistance, were included in the study
(Table 1). One isolate per patient was investigated except in one instance, where
two isolates with different antibiograms were recovered from one patient (Table
1). All isolates were identified as MSSA, typed by AR typing, and screened for
the presence or absence of the mecA gene by PCR as described previously (56).
Isolates were stored at ⫺80°C in Protect bacterial preserver vials (Technical
Services Consultants Ltd., Heywood, United Kingdom) and cultured on tryptone
soya agar (Oxoid Ltd., Basingstoke, United Kingdom) prior to incubation overnight at 37°C.
During the course of the present study, PCR used for SCCmec typing and
nucleotide sequence analysis of resulting amplimers showed that some GrMSSA
isolates harbored segments of DNA with sequences similar to regions of SCCmec
elements in MRSA isolates recovered in Ireland between 1989 and 2002. All 54
of these earlier isolates exhibited MLST sequence type 8 (ST8) and variant
subtypes of SCCmec II (59). Isolates representative of each of the variant
SCCmec II subtypes identified during that study (n ⫽ 23) were spa typed, and all
exhibited the same spa type (t190). These 23 MRSA isolates recovered between
1989 and 2002 were subsequently investigated for carriage of ccrAB4 because the
earlier study was undertaken before amplification of ccrAB4 formed part of any
SCCmec typing scheme.
Chemicals, enzymes, and oligonucleotides. All chemicals used were of analytical grade or molecular biology grade and were purchased from the SigmaAldrich Chemical Co. (Tallaght, Dublin, Ireland). Enzymes were purchased from
the Promega Corporation (Madison, WI) or Roche Diagnostics Ltd. (Lewes,
East Sussex, United Kingdom) and were used according to the manufacturer’s
instructions. DNA molecular weight markers were purchased from Promega.
Oligonucleotide primers were custom synthesized by the Sigma-Aldrich Company Ltd. (Haverhill, United Kingdom).
Molecular characterization. All isolates were investigated by SCCmec typing
PCR, spa typing, and MLST. Genomic DNA was extracted using the DNeasy kit
(Qiagen, Crawley, United Kingdom) according to the manufacturer’s instructions. PCRs were performed using GoTaq Flexi DNA polymerase (Promega)
according to the manufacturer’s instructions using the published protocols for
each method described below. Amplifications were performed in a ThermoHybaid Multiblock system thermal cycler (Thermo-Hybaid, Ashford, Middlesex,
United Kingdom). PCR products were visualized by conventional agarose gel
electrophoresis and purified with the GenElute PCR cleanup kit unless otherwise indicated in the appropriate sections below (Sigma-Aldrich). Sequencing
was performed commercially by Cogenics (Essex, United Kingdom) using an
ABI 3730xl DNA analyzer (Applied Biosystems, Foster City, CA).
SCCmec typing PCRs. Three multiplex SCCmec typing PCRs were performed
with template DNA from each isolate to determine if they harbored segments of
SCCmec elements I to VI. Two of these methods were described previously by
Kondo et al. (32), where they were named MPCR-1 and MPCR-2, respectively,
and the third method was described previously by Oliveira and de Lencastre (47).
The first multiplex PCR (MPCR-2), referred to here as PCR scheme 1, amplifies
the class A, B, and C mec complexes (32). The second multiplex SCCmec typing
method (MPCR-1), referred to here as PCR scheme 2, detects the presence of
the ccr complex genes ccrAB1, ccrAB2, ccrAB3, ccrAB4, and ccrC (32). The third
multiplex SCCmec typing method, referred to here as PCR scheme 3, amplifies
partial nucleotide sequences in the mec complex (mecI gene only) and in the
junkyard regions of SCCmec I to IV, including subtypes IA (I.1.1.3), IIIA (III.1),
and IIIB (III.1.1.3) (47). In each of these multiplex PCR schemes, amplification
of the mecA gene was used as an internal control.
The following S. aureus control strains and clinical isolates were used as
positive controls for SCCmec typing PCR as indicated: phenotype II 43.2
(SCCmec I, ccrAB1) (59), CA05 (SCCmec IV, class B mec, ccrAB2) (36), WIS
(class C mec) (29), 07.4/0237 (SCCmec II) (59), JCSC 4744 (IVA) (47), M00/
0005.2 (ccrAB4), and E0898 (SCCmec III, class A mec, ccrAB3 ccrC).
All SCCmec typing amplimers were sequenced to confirm their identities using
the PCR primers yielding those amplimers. Analysis of chromatograms and
sequences was carried out using the TraceViewer software program (version
1.1.3; CodonCode Corporation, Massachusetts) and DNA Strider 1.3f11 software (CEA/Saclay, Gif-sur-Yvette, France), respectively. Homology searches
were performed using BLAST software (http://ncbi.nih.gov/BLAST).
MLST. MLST was performed as described previously (15). PCR products were
purified using the Qiaquick 96 PCR purification kit (Qiagen). Analysis of chromatograms and sequences was performed using the BioNumerics software package (version 5.0; Applied Maths, Ghent, Belgium). The alleles at each of the
seven housekeeping loci were identified by comparison with sequences held in
the MLST database (http://saureus.mlst.net). The allelic profile and hence the
ST of each isolate was also determined using this database. The stringent group
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TABLE 1. Patients’ MRSA histories and phenotypic and genotypic characteristics of the 25 MSSA isolates investigated
Amplimer(s) obtained with SCCmec
typing PCRg

Resistance pattern
Isolatea

MRSA
historyb

Aminoglycosides/
aminocyclitolc

Other
antimicrobialsd

AMP, CAD, CIP,
ERY, ETBR,
LIN, MC,
PMA
CIP, ERY, LIN,
MUPe
AMP, CAD, CIP,
ERY, ETBR,
MC, MUP,e
PMA, TMP
AMP, CAD, CIP,
ERY, ETBR,
MC, MUP,e
PMA
AMP, CAD, CIP,
ERY, ETBR,
MC, PMA
AMP, CIP
AMP, CIP
AMP, CAD,
CIP,e MC,
TMP
AMP, SUL, TET,
TMP
AMP, ERY,
FUS, LIN,
MUP
ERY, FUS, LIN,
MUP
AMP, CAD, CIP,
ERY, LIN,
MUP
AMP
AMP, TMP
AMP, CAD,
TMP
AMP, ERY, LIN,
MUP, TET
AMP, CAD,e
TET
AMP, CAD, LIN,
MUP

M06/0075

GrMRSA

GEN, KAN, NEO,
SPC, STR, TOB

M06/0179

GrMRSA

M05/0146

GrMRSA

GEN, KAN, NEO,
SPC, STR, TOB
GEN, KAN, NEO,
SPC, STR, TOB

M02/0021

GrMRSA

AMI,e GEN,
KAN, NEO,
SPC, STR, TOB

M04/0269

GrMRSA

GEN, KAN, NEO,
SPC, STR, TOB

M06/0324
M06/0329
M05/0065

None
None
None

GEN, KAN, TOB
GEN, KAN, TOB
GEN, KAN, TOB

M05/0330

None

M06/0004

GsMRSA

GEN, KAN, NEO,
STR, TOB
GEN, KAN, TOB

M06/0288

Not
known
Not
known

GEN, KAN, NEO,
TOB
GEN, KAN, TOB

M05/0077
M04/0261
M05/0232

None
None
None

GEN, KAN, TOB
GEN, KAN, TOB
GEN, KAN, TOB

M06/0378

None

GEN, KAN, TOB

M04/0262

None

GEN, KAN, TOB

M05/0084

GsMRSA

M05/0167

GsMRSA

AMI,e GEN,
KAN, NEO,
TOB
GEN, KAN, TOB

M05/0045
M05/0080
M05/0223

GsMRSA
GsMRSA
None

GEN, KAN, TOB
GEN, KAN, TOB
GEN, KAN, TOB

M04/0260
M05/0133
M06/0392

None
None
None

GEN, KAN, TOB
GEN, KAN, TOB
GEN, KAN, TOB

M05/0083

AMP, ETBR,
LIN, MUP
AMP
AMP TMP
AMP, CAD,
FUS, MUP
ERY
ERY
AMP, CAD, TET

spa
clusterf

spa
type

MLST
CC

ST

PCR
scheme 1
(mec)

PCR scheme
2 (ccr)

PCR
scheme 3i

1

t190

8

ST8

Negative

ccrAB4 and
ccrAB2

mecI and
dcs

1

t190

8

ST8

Negative

1

t190

8

ST8

Negative

ccrAB4 and
ccrAB2
ccrAB4

mecI and
dcs
Negative

1

t190

8

ST8

Negative

ccrAB4

Negative

1

t3209

8

ST8

Negative

Negative

dcs

2
2
2

t2658
t2658
t2658

8
8
8

ST8
ST8
ST8

Negative
Negative
Negative

Negative
Negative
Negative

Negative
Negative
Negative

2

t064

8

ST8

Negative

Negative

Negative

Singleton

t088

5

ST5

Negative

ccrAB4

Negative

Singleton

t088

5

ST5

Negative

ccrAB4

Negative

3

t379

22

ST22

Negative

Negative

Negative

3
3
3

t005
t005
t891

22
22
22

ST22
ST22
ST854

Negative
Negative
Negative

Negative
Negative
Negative

Negative
Negative
Negative

4

t127

1

ST1

Negative

Negative

Negative

4

t1383

1

ST1135h

Negative

Negative

Negative

Singleton

t3500h

45

ST1096h

Negative

Negative

Negative

Singleton

t3500h

45

ST1096h

Negative

Negative

Negative

Singleton
Singleton
Singleton

t2078
t2078
t021

101
101
30

ST101
ST101
ST30

Negative
Negative
Negative

Negative
Negative
Negative

Negative
Negative
Negative

5
5
Singleton

t084
t491
t164

15
15
20

ST582
ST582
ST1134h

Negative
Negative
Negative

Negative
Negative
Negative

Negative
Negative
Negative

a
One isolate per patient was included except in one instance, where two isolates with different antibiograms (M06/0179 and M06/0075) were recovered from one
patient. Isolates shown with bold and underlined typeface yielded amplimers by SCCmec typing PCR.
b
Not known, data on patient’s MRSA history were not available.
c
Aminoglycosides/aminocyclitols tested were as follows: AMI, amikacin; GEN, gentamicin; KAN, kanamycin; NEO, neomycin; SPC, spectinomycin; STR, streptomycin; TOB, tobramycin.
d
Other antimicrobials tested included the following: AMP, ampicillin; CAD, cadmium acetate; CHL, chloramphenicol; CIP, ciprofloxacin; ERY, erythromycin;
ETBR, ethidium bromide; FUS, fusidic acid; LIN, lincomycin; MC, mercuric chloride; MUP, mupirocin; PMA, phenyl mercuric acetate; RIF, rifampin; SUL,
sulfonamide; TET, tetracycline; TMP, trimethoprim; VAN, vancomycin.
e
Intermediately susceptible to the antimicrobial indicated.
f
The BURP algorithm was applied to all isolates for the determination of clusters of related isolates based on the spa types identified (40).
g
Sequencing was performed to confirm the identities of all amplimers obtained by SCCmec typing PCR. Negative, no PCR amplimers were obtained.
h
New STs or spa types identified in the present study.
i
See reference 47.
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TABLE 2. Primers used in the present study

Primer application

Amplification and
sequencing of the
SCCmec IID
remnant

Amplification of
ccrAB4 from SCCCI in S.
epidermidis from
historic Irish
nosocomial ST8t190 MRSA
isolates
Determination of the
location of ccrAB4
in GrMSSA
isolates with the
SCCmec IID
remnant and in
MRSA isolates
Determination of the
location of ccrAB4
in GrMSSA
isolates with
ccrAB4 only
Determination of the
location of dcs in
the GrMSSA
isolate with dcs
only
a
b
c

Primer
pair(s)

Nucleotide
coordinates

Nucleotide sequence (5⬘–3⬘)

SCCmec region amplified

4684–4703a

IRLII F

CTCTGCGTATCAGTTAATGA

Left chromosomal/SCCmec
junction to ccrA2

ccrA R
ccrA2 F5
Tn554 R
N044 F
TN554 R6
Tn554 F7
mecI R2
mecI P2
dcs R1
dcs F

GCTTCGATAGCCTGTTTCTG
AACTTATCGAGATATTAGCC
AAGCTATCCACGTTCAATCTCAAC
AAATAGTATAATGCTCGGTC
TGGAGACATATTAGACACAA
GCGATAAAGGACAGTGACTT
AGGAAACAATCAAGTCGTTG
ATCAAGACTTGCATTCAGGC
AGACGAAGATAAGAAAGAAC
GTCAATGAGATCATCTACAT

25490–25471a
25265–25284a
32442–32419a
30481–30500a
36440–36421a
36191–36210a
42507–42488a
42428–42447a
56433–56414a
56109–56128a

orfX R

CCCAAGGGCAAAGCGAC

57826–57810a

␣4.3

AGCGTATGAATCAAAA

27155–27170

␤4.3

CGATGACAAATTAAAAT

27907–27891b

ccrB4 F

TTTCGTCCATTACCTACATC

27075–27056b

LCIVb R

TGAGGAGTTTAACAAGTTAT

ccrB4 F

TTTCGTCCATTACCTACATC

27075–27056b

orfX R

CCCAAGGGCAAGCGAC

57826–57810a

dcs F

GTCAATGAGATCATCTACAT

56109–56128a

orfX R

CCCAAGGGCAAGCGAC

57826–57810a

b

ccrA2 to Tn554
N044 to Tn554
Tn554 to mecI
mecI to dcs
dcs to right chromosomal/
SCCmec junction

Reference

59

59
This
59
This
This
This
This
47
This
59

study
study
study
study
study
study

59
ccrA4 to ccrB4 of S.
epidermidis SCC-CI

This study

This study
ccrB4 to left chromosomal/
SCCmec IID remnant
junction

160–141c

This study

This study
ccrB4 to orfX

This study

59
dcs to orfX

59

59

Nucleotide coordinates from the type II SCCmec type element, accession number D86934.
Nucleotide coordinates from the Staphylococcus epidermidis ATCC 12228 composite island SCC-CI, accession number BK001539.
Nucleotide coordinates from the SCCmec IID remnant, accession number AM983545.

definition for clonal complex (CC) determination was used, where isolates with
specific STs are assigned to a particular CC if they are related to at least one
other ST in that CC at six out of the seven MLST loci used (16). Isolates that do
not share alleles at six of the seven MLST loci with any other ST in the MLST
database are deemed singletons (16).
spa typing. The primers and thermal cycling conditions recommended by the
European Network of Laboratories for Sequence Based Typing of Microbial
Pathogens (SeqNet) were used for spa typing (http://www.seqnet.org/). The Ridom StaphType software program, version 1.3 (Ridom Gmbh, Wurzburg, Germany), was used for spa sequence analysis, assignment of spa types, and BURP
(based upon related patterns) spa clonal complex determination. The default
parameters for cluster definition were used for BURP. These include the exclusion of spa types that are shorter than five repeats because they are deemed too
short for the deduction of evolutionary history and the clustering of spa types

only if the cost (i.e., the steps of evolution between two different spa types) is less
than or equal to four (40).
Nucleotide sequencing of SCCmec remnant in isolate M06/0075. The entire
nucleotide sequence of the SCCmec remnant from one MSSA isolate, M06/0075,
was determined. This isolate was selected because, along with another isolate
recovered from the same patient (M06/0179), it yielded the greatest number of
SCCmec typing amplimers. Sequencing was undertaken to determine if these
amplimers were part of a larger remnant of SCCmec. The element was amplified
and sequenced from the left chromosomal SCCmec junction to orfX using a
combination of previously described and newly designed overlapping primers
based on the published SCCmec II nucleotide sequence (http://www.ncbi.nlm
.nih.gov/sites/entrez; accession number D86934). The SCCmec II nucleotide
sequence was chosen because three out of the four amplimers produced by
GrMSSA isolate M06/0075 indicated the presence of an SCCmec remnant with
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closest similarity to the type II SCCmec element (i.e., dcs, mecI, and ccrAB2).
The primers used are listed in Table 2.
DNA fragments for sequencing were obtained by PCR amplification of chromosomal DNA using either the Expand high-fidelity PCR system (Roche) for the
primer pair dcs F and orfX R or the Expand long-template PCR system (Roche)
for all other primer sets according to the manufacturer’s instructions. Amplified
DNA was separated by agarose gel electrophoresis using at least 5-l volumes of
each PCR product. Amplimers were purified using either the GenElute PCR
cleanup kit (Sigma-Aldrich) or the Qiaex II gel extraction kit (Qiagen) prior to
direct sequencing using primer walking. Analysis of chromatograms and sequences and homology searches were performed as described above for sequencing of the SCCmec typing amplimers.
Investigation of MRSA isolates for presence of ccrAB4. Twenty-three MRSA
isolates with the same MLST/spa type genetic background and similar SCCmec
regions to those of the GrMSSA isolate M06/0075 were investigated to see
whether they harbored ccrAB4. The ccrAB4 gene was amplified using the primers
␣4.3 and ␤4.3 (Table 2). This primer pair was designed to be specific for the
ccrAB4 gene from S. epidermidis because the ccrAB4 gene identified in the
GrMSSA isolates in this study had 100% homology with ccrAB4 from the S.
epidermidis composite island SCC-CI. PCRs were performed using GoTaq Flexi
DNA polymerase (Promega) according to the manufacturer’s instructions. Amplifications were performed in a Thermo-Hybaid Multiblock system thermal
cycler (Thermo-Hybaid, Ashford, Middlesex, United Kingdom) with an initial
denaturation step at 94°C for 2 min, followed by 30 cycles of denaturation at 94°C
for 2 min, annealing at 48°C for 1 min, and elongation at 72°C for 2 min. A final
elongation step was performed for 2 min at 72°C. The MRSA isolate HDE288,
which harbors SCCmec VI with a different ccrAB4 allotype from that found in S.
epidermidis, and S. epidermidis ATCC 12228, harboring SCC-CI with ccrAB4,
were used as negative and positive controls, respectively, for this PCR assay (41,
48). Isolates harboring ccrAB4 genes identical to those in S. epidermidis yield
an 800-bp product using this primer pair, and isolates harboring ccrAB4 from
S. aureus should yield no product. PCR products were visualized by agarose
gel electrophoresis and purified using the GenElute PCR cleanup kit (SigmaAldrich). The identities of amplimers from isolates representative of each
variant SCCmec II subtype (IIA [II.3.1.1], IIB [II.3.2.1], IIC [II.3.3.1], IID
[II.3.1.2], and IIE [II.3.3.2]) among these MRSA isolates were confirmed by
sequencing.
Determination of location of ccrAB4. Two primers, ccrB4 F and LCIVb R,
based on the S. epidermidis ccrAB4 gene and the left extremity of the SCCmec
IID remnant, respectively, were designed to investigate the location of ccrAB4 in
the two GrMSSA isolates with the SCCmec IID remnant (M06/0075 and M06/
0179) recognized in the present study and in five MRSA isolates representative
of each SCCmec II variant subtype IIA to IIE that were also found to harbor
ccrAB4. A second primer pair, ccrB4 F and orfX R, based on the S. epidermidis
ccrAB4 gene sequence and orfX, respectively, was selected to locate ccrAB4 in the
four GrMSSA isolates that yielded ccrAB4 only (M02/0021, M05/0146, M06/
0004, and M06/0288). Primer sequences are shown in Table 2. DNA fragments
were obtained by PCR amplification of chromosomal DNA using the Expand
long-template PCR system (Roche) according to the manufacturer’s instructions.
Amplified DNA was separated by agarose gel electrophoresis using 5-l volumes
of each PCR product.
Determination of location of dcs. The Primer pair dcs F and orfX R (Table 2)
was used to determine the location of dcs in the GrMSSA isolate (M04/0269)
that yielded the dcs amplimer only by SCCmec typing PCR. DNA fragments were
obtained by PCR amplification of chromosomal DNA as described above.
Investigation of GrMSSA isolates with SCCmec/SCC-associated DNA using
real-time PCR MRSA rapid detection assays. The seven GrMSSA isolates harboring SCCmec/SCC-associated DNA identified in the present study were tested
with two commercially available real-time PCR assays for the rapid detection of
MRSA in clinical specimens to determine if such isolates would be detected as
MRSA. Isolates were tested with the BD GeneOhm MRSA assay (BD Diagnostics, Ste Foy, Quebec, Canada) using a Smart Cycler II thermal cycler (Cepheid,
Sunnyvale, CA) and with the Xpert MRSA assay using a GeneXpert DX system
(version 1.2) real-time PCR platform (Cepheid) according to the manufacturer’s
instructions as described previously (52). S. aureus ATCC 25923 (MSSA), S.
aureus ATCC 29213 (MSSA), S. aureus ATCC 43300 (MRSA) and S. epidermidis
ATCC 12228 were used as control strains with both systems.
Nucleotide sequence accession numbers. The nucleotide sequence of the
SCCmec IID remnant was submitted to the GenBank database under accession
number AM983545.
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RESULTS
The purpose of the present study was to investigate whether
MSSA isolates from patients in an environment where MRSA
has been endemic for many years harbor segments or remnants
of SCCmec. Twenty-five gentamicin-resistant MSSA isolates
were investigated by AR typing, SCCmec typing PCR, and
genotyping using MLST and spa typing (Table 1). The majority
of isolates (21/25; 84%) were multiantibiotic resistant (i.e.,
resistant to two or more classes of non-beta-lactam antibiotics
[Table 1]). All lacked the mecA gene.
SCCmec typing PCR. Template DNA from all 25 isolates
was tested for the presence of mec complex types A, B, and C
(PCR scheme 1), ccr genes 1 to 5 (PCR scheme 2), and the
various junkyard regions (including mecI) of SCCmec I to IV
(PCR scheme 3). All isolates were mecA negative by PCR
schemes 1 to 3 and failed to yield any mec complex amplimers
when PCR scheme 1 was used, but 7/25 (28%) isolates yielded
at least one SCCmec amplimer each when PCR scheme 2 or 3
was used (Table 1). These seven isolates belonged to the following three MLST/spa genotypes: ST5/t088 (n ⫽ 2), ST8/
t3209 (n ⫽ 1), and ST8/t190 (n ⫽ 4) (Table 1).
Investigation of SCCmec amplimers generated from seven
GrMSSA isolates. Two isolates, M06/0075 and M06/0179 (recovered from the same patient after an interval of 4 months),
each yielded four amplimers: two amplimers of 1,287 bp and
937 bp were obtained using PCR scheme 2, while PCR scheme
3 yielded a 342-bp and a 209-bp amplimer (Table 1). The
1,287-bp amplimer was identical in size to an amplimer usually
obtained with PCR scheme 2 from MRSA template DNA
carrying the ccrAB4 gene (Table 1). Nucleotide sequence analysis of this 1,287-bp amplimer showed 88% and 91% homology
with ccrAB4 from the MRSA SCCmec element SCCmecNI (14)
and SCCmec VI (48), respectively, but showed 100% homology
with ccrAB4 from the SCC composite island SCC-CI, found in
S. epidermidis ATCC 12228 (41). The 937-bp amplimer was
identical in size to an amplimer usually obtained with PCR
scheme 2 from MRSA template DNA carrying the MRSA
ccrAB2 gene and exhibited 100% sequence homology with
ccrAB2. The 342-bp amplimer obtained with PCR scheme 3
was identical in size to an amplimer usually obtained with
MRSA template DNA using PCR scheme 3 corresponding to
the dcs region located downstream of mecA in SCCmec types
I, II, and IV in MRSA isolates. Sequence analysis showed that
this amplimer exhibited 100% sequence homology with dcs
from MRSA. The 209-bp amplimer obtained with PCR scheme
3 was identical in size to an amplimer usually obtained with
MRSA template DNA using PCR scheme 3 corresponding to
the mec complex gene mecI and exhibited 100% sequence
homology with mecI.
Four isolates (M05/0146, M02/0021, M06/0004, and M06/
0288) each yielded one 1,287-bp amplimer by PCR scheme 2.
This amplimer exhibited 100% sequence homology with
ccrAB4 from SCC-CI in S. epidermidis ATCC 12228.
One isolate (M04/0269) yielded one 342-bp amplimer by
PCR scheme 3 (Table 3). This amplimer exhibited 100% sequence homology with the dcs region.
Genotyping. MLST grouped the 25 isolates into nine clonal
complexes, with 13/25 (52%) isolates belonging to either CC8
(n ⫽ 9) or CC22 (n ⫽ 4) (Table 1). The seven GrMSSA
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TABLE 3. Summary of findings from the present study and from previous studies reporting SCCmec fragments in
methicillin-susceptible S. aureus

No. of MSSA isolates
with SCCmec regions
(source)a

7 (four Irish hospitals)

2 (i.v. drug users)
26 (regions
worldwide)
6 (French hospitals)

1 (nasal swab, HCW)

169 (60 French
hospitals)

Method used to detect SCCmec
segments (reference)

PCR to detect mec complexes A,
B, and C (32)
PCR to detect ccrAB1 to –4, ccrC
(32)
Multiplex PCR (47)
PCR to detect ccrAB1 (28)
Multiplex PCR (47)
Real-time PCR (IDI-MRSA assay)
to amplify the right SCCmec/
orfX junction
PCR detection of mecA (39)
PCR detection of ccrAB1, ccrAB2,
and ccrAB3 (36)
Multiplex PCR (47)
PCR detection of HVR-IS431pUB110-IS431-dcs-orfX
Real-time PCR (Genotype MRSA
Direct) to amplify right
SCCmec/orfX junction
PCR to confirm the right SCCmec/
orfX junction (7)
PCR detection of mecA (50)
PCR to detect ccrAB1, ccrAB2,
and ccrAB3 (46)
Real-time PCR (IDI-MRSA assay)
to amplify the right SCCmec/
orfX junction
PCR to investigate HVR-IS431pUB110-IS431-dcs-orfX (13) (2
isolates only investigated)
PCR to detect ccrAB1, ccrAB2,
and ccrAB3 (28) (14 isolates
investigated)

SCCmec segments
found (nb)

MLST/spa
genotype (nb)

Further
analysis of
SCCmecassociated
sequences
undertaken

Reference

ccrAB2c (2);

ST8/t190 (4)

ccrAB4c (6)

ST8/t3209 (1)

Yese

mecIc (2); dcsc (3)
ccrAB1c
dcsc
Right SCCmec/orfX
junctiond

ST5/t088 (2)
Not done

No

6

Not done

No

25

IS431-pUB110, dcs

ST8/t008 (1)

No

13

Right SCCmec/orfX
junctionc

t498

No

57

Right SCCmec/orfX
junction

ST8/t008 (isolate 1)

No

11

dcs only (isolate 1)

ST8/t024 (isolate 2)

Present study

IS431-pUB110-IS431-dcs

HVR-IS431-pUB110IS431-dcs (isolate 2)

a

HCW, health care worker; i.v., intravenous.
n, no. of isolates.
Identity of amplimer(s) confirmed by DNA sequencing.
d
IDI-MRSA assay amplimer identity was confirmed by conventional endpoint PCR.
e
A 26-kb SCCmec remnant was sequenced from one ST8/t190 isolate, and ccrAB4 was found to be located 5,549 bp upstream of SCCmec.
b
c

isolates that yielded amplimers by SCCmec typing PCR belonged to either ST8 (n ⫽ 5) or ST5 (n ⫽ 2) (Table 1). Among
the isolates that did not yield SCCmec typing amplimers, the
majority (14/18) belonged to a range of STs other than ST8 and
ST5 (Table 1). Four isolates that did not yield SCCmec amplimers belonged to ST8 but had different spa types (t2658 and
t064) from those of the five ST8 isolates that yielded SCCmec/
SCC amplimers. The latter exhibited spa types t190 and t3209.
BURP analysis assigned the spa types of these nine ST8 isolates into two clusters, one consisting of t190 and t3209 isolates
and the other consisting of t2658 and t064 isolates. The remaining 16 isolates investigated fell into three additional spa
clusters and five singleton groups. Two isolates exhibited a
novel ST and spa type (Table 1). Two isolates with spa types
t164 and t1383, respectively, exhibited two different novel
MLST types.
Characterization of a novel SCCmec remnant in GrMSSA
M06/0075. The GrMSSA isolate M06/0075 (genotype ST8/
t190) was selected for more-detailed analysis because it was

one of the two isolates that yielded the greatest number of
amplimers with the SCCmec PCR typing schemes (Table 1).
Analysis of the entire nucleotide sequence of the SCC element
from the left chromosomal SCC junction to orfX revealed that
this GrMSSA isolate harbored a large portion of an SCCmec
element consisting of a ca. 26-kb contiguous sequence with a
genomic organization similar to that of a variant SCCmec II
element, SCCmec IID (II.3.1.2), previously identified among
ST8 MRSA isolates from Ireland (59) (Fig. 1).
Although SCCmec IID (II.3.1.2) has not been fully sequenced, its genomic organization was determined previously
by PCR amplification and comparison to the expected size for
amplimers from fully and partially sequenced SCCmec II variant elements SCCmec IIA (II.3.1.1) and IIE (II.3.3.2), respectively (shown in Fig. 1) (59). The variant SCCmec elements IIA
to IIE and IVE/IVF were identified and characterized previously by this laboratory (59). SCCmec IID (II.3.1.2) is similar
in its genetic organization to SCCmec IIE (II.3.3.2), which has
been sequenced in full (59). SCCmec IID (II. 3.1.2) and
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FIG. 1. Schematic diagram showing the genetic organization of the novel SCCmec IID (II.3.1.2) remnant from GrMSSA isolate M06/0075
determined in the present study (a) and the corresponding organization of SCCmec elements IID (II.3.1.2) (b), IIA (II.3.1.1) (c) IIE (II.3.3.2), (d),
and II (II.1.1.2) (e), determined previously (28, 59). The structure of the SCCmec remnant from M06/0075 was determined by sequencing of the
entire element (accession number AM983545) and was found to have closest similarity to SCCmec IID (II.3.1.2). The left and right extremities
of the SCCmec elements/remnant are indicated with square brackets. Panels a to d also show the location of ccrAB4 identified in the present study,
5,549 bp upstream of the left chromosomal/SCCmec junction region of the SCCmec IID remnant and SCCmec elements IID (II.3.1.2), IIA
(II.3.1.1), and IIE (II.3.3.2), respectively. Panel f shows the location of dcs upstream of orfX, identified in the one GrMSSA isolate (M04/0269) that
yielded dcs only by SCCmec typing PCR. Panel g shows the location of ccrAB4 relative to orfX, a structure identified in the four GrMSSA isolates
(M02/0021, M05/0146, M06/0004, and M06/0288) that yielded ccrAB4 only by SCCmec typing PCR. The ccrAB4 gene identified in the GrMSSA
and MRSA isolates in the present study demonstrated 100% homology with ccrAB4 previously identified in the composite island SCC-CI in S.
epidermidis strain ATCC 12228 (41). The DNA sequence between ccrAB4 and the SCCmec IID remnant in M06/0075 and between ccrAB4 and
orfX in M02/0021 in each case was 98.5% homologous with the DNA region between ccrAB4 and SCCpbp4 in SCC-CI from S. epidermidis
(accession number BK001539, bases 26100 to 24570 and bases 23009 to 18990) except that a ca. 1.5-kb contiguous DNA sequence in this region
of SCC-CI (bases 24569 to 23010) was absent in M06/0075 and in M02/0021. This SCC-CI region encodes a spermidine acetyltransferase, a
truncated transposase, and the type I restriction proteins HsdS and HsdR, as well as nine other hypothetical proteins (41). All of these open reading
frames were also present in the DNA sequences from M06/0075 and M02/0021 referred to above, apart from the partial DNA sequence of one
hypothetical protein and the complete sequence of another.
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SCCmec IIE (II.3.3.2) differ in the J2 and mec complex regions, but the J2 and mec complex regions of SCCmec IID
(II.3.1.2) are identical to the corresponding regions of SCCmec
IIA (II.3.1.1), which have also been sequenced (Fig. 1) (59).
Therefore, although the SCCmec remnant of M06/0075 was
most similar in genomic organization to SCCmec IID (II.3.1.2),
its nucleotide sequence was compared with the nucleotide sequences of the J1, J3, and ccr complex regions of SCCmec IIE
(II.3.3.2) and with those of the J2 and mec complex regions of
SCCmec IIA (II.3.1.1). The J1 and ccr complex regions of
M06/0075 shared 99.5% homology with the corresponding region of SCCmec IIE (II.3.3.2) (Fig. 1). The J2 region shared
99% homology with the J2 region of SCCmec IIA (II.3.1.1).
Combining of data from the J1, J2, and ccr complex regions
indicated that the SCCmec remnant of M06/0075 most closely
resembles a type IID (II.3.1.2) SCCmec element (Fig. 1).
The major difference between SCCmec IID (II.3.1.2) and
the SCCmec remnant in M06/0075 was in the mec complex and
J3 regions. The mec complex of M06/0075 consisted of IS1182
inserted within the mecI gene near the 3⬘ end at the exact
nucleotide position and resulting in the same 16-bp deletion
within mecI as previously identified in the class A.4 mec complex found in SCCmec IIA (II.3.1.1) and SCCmec IID (II.3.1.2)
(59). There were five base pair differences between IS1182
from class A.4 mec and M06/0075, including the final base of
IS1182, which was absent in M06/0075. In addition, the remainder of the mecI gene (located immediately downstream of
IS1182 in class A.4 mec) and the rest of the mec complex,
including the mecR1, mecA, and IS431 genes, were absent in
M06/0075 (Fig. 1). The region immediately adjacent to IS1182
in M06/0075 shared 99.5% homology with the region extending
from ca. 500 bp downstream of IS431 in SCCmec IIE (II.3.3.2)
to orfX at the extreme right chromosomal SCCmec junction.
This region of both SCCmec IIE (II.3.3.2) and SCCmec IID
(II.3.1.2) consists of a noncoding region normally found between IS431 and dcs and the dcs region that has been identified
previously in SCCmec I, II, and IV. The orfX gene was identified immediately adjacent to the SCCmec remnant in M06/
0075. Furthermore, this SCCmec remnant was integrated at the
same nucleotide position within orfX as other SCC/SCCmec elements. The 15-bp direct repeat sequence found at the right
extremity of all SCCmec (DR-R) elements identified to date
was also identified in M06/0075, as was the 26-bp inverted
repeat sequence (IR-R), which had 100% similarity to the
IR-R sequences of SCCmec II (II.1.1.2), IIE (II.3.3.2), and IVb
(IV.2.1.1). Sequencing of the entire SCCmec remnant from the
left chromosomal SCCmec junction to orfX failed to locate the
ccrAB4 gene within this element.
Investigation of ST8/t190 MRSA isolates for carriage of
ccrAB4 outside SCCmec. Nosocomial MRSA isolates (n ⫽ 23)
with the same MLST and spa type as and similar SCCmec
sequences to those of GrMSSA isolate M06/0075 were investigated to determine if they also harbored ccrAB4 with 100%
homology to ccrAB4 of SCC-CI from S. epidermidis. These
included isolates representative of each variant SCCmec II
subtype previously identified among ST8/t190 MRSA isolates
recovered from Irish hospitals between 1989 and 2002 (59).
When these isolates were originally SCCmec typed, amplification of ccrAB4 was not part of any published SCCmec typing
scheme (59). All 23 isolates yielded amplimers of the expected
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size (800 bp) using the primer pair ␣4.3 and ␤4.3, which are
specific for ccrAB4 from SCC-CI from S. epidermidis (Table 2).
For each set of PCR experiments, S. aureus HDE288, which
harbors SCCmec ccrAB4 (48), failed to yield any amplimers,
whereas template DNA from S. epidermidis ATCC 12228, harboring SCC-CI ccrAB4 (41), yielded the expected 800-bp amplimer, indicating that the primers ␣4.3 and ␤4.3 are specific
for ccrAB4 from SCC-CI in S. epidermidis. The identities of the
amplimers from five MRSA isolates representative of each
variant SCCmec subtype IIA to IIE (AR13/0132 [IIA, 3.1.1],
AR05/0.1345 [IIB, II.3.2.1], AR14/0246 [IIC, II.3.3.1], AR13/
3698 [IID, II.3.1.2], and AR13.1/3330.2 [IIE, II.3.3.2])(59) was
confirmed by DNA sequencing and in each case showed 100%
homology with ccrAB4 in SCC-CI from S. epidermidis. The
genomic organization of the SCCmec elements harbored by
these MRSA isolates has been fully determined previously
and showed that these isolates do not harbor ccrAB4 within
SCCmec (59). These results demonstrate that, like the SCCmec IID
(II.3.1.2) remnant in the GrMSSA isolate M06/0075, ccrAB4 is
present in these ST8/t190 MRSA isolates with variant SCCmec
elements IIA to IIE but it is not located within SCCmec.
Determination of location of ccrAB4. In total, six GrMSSA
isolates harbored ccrAB4 with 100% homology with that of the
SCC-CI element from S. epidermidis. These included the two
ST8/t190 GrMSSA isolates which also harbored the SCCmec
IID remnant and the four GrMSSA isolates (genotypes ST8/
t190 [n ⫽ 2] and ST5/t088 [n ⫽ 2]) that yielded only the ccrAB4
amplimer (Table 1). In addition, the 23 ST8-t190 MRSA isolates with SCCmec IIA to IIE investigated were also found to
harbor this ccrAB4 gene. PCR amplification of the region between the left extremity of the SCCmec IID remnant and the
ccrAB4 gene in the two GrMSSA isolates M06/0075 and M06/
0179 and from the left extremity of SCCmec elements IIA to
IIE to ccrAB4 in the five MRSA isolates representative of each
Irish variant SCCmec II subtype resulted in each isolate yielding a ca. 7-kb amplimer. DNA sequence analysis of this amplimer from one representative GrMSSA isolate, M06/0075,
confirmed that ccrAB4 was located 5,549 bp upstream of the
left SCCmec IID remnant junction (Fig. 1). The region between ccrAB4 and the SCCmec IID remnant in M06/0075
exhibited 98.5% DNA sequence homology to the corresponding DNA sequence located between ccrAB4 and SCCpbp4 in
SCC-CI from S. epidermidis (accession number BK001539,
bases 26100 to 24570 and bases 23009 to 18990), except that a
ca. 1.5-kb contiguous DNA sequence in this region of SCC-CI
(bases 24569 to 23010) was absent in M06/0075. The region
located between ccrAB4 and SCCpbp4 in SCC-CI encodes nine
hypothetical proteins, as well as a spermidine acetyltransferase, a truncated transposase, and the type I restriction proteins HsdS and HsdR (41). All of these open reading frames
were also present in the DNA sequence identified between
ccrAB4 and the SCCmec IID remnant apart from the partial
DNA sequence of one hypothetical protein and the complete
sequence of another. All direct-repeat and inverted repeat
(IR) sequences previously described at the left SCCpbp4/
SCC-CI junction region in S. epidermidis (41) were also identified at the junction region of the DNA sequence located
between ccrAB4 and the SCCmec IID remnant in M06/0075.
The DNA sequence of the SCCmec IID remnant J1 region was
found immediately after the SCC-CI and SCCpbp4 IR se-
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quence and was found to be 100% homologous to the DNA
sequence that normally lies immediately after the left IR sequence of SCCmec IID. The left IR of SCCmec was absent.
Figure 1 shows a schematic representation of the location of
ccrAB4 in relation to SCCmec in some of the variant subtypes
investigated, including SCCmec IIA, IID, and IIE. PCR amplification of the region between ccrAB4 and orfX in the four
GrMSSA isolates that yielded ccrAB4 only by SCCmec typing
PCR (Table 1) also yielded a 7-kb amplimer. DNA sequence
analysis of the 7-kb amplimer from one representative isolate,
M02/0021, revealed that the ccrAB4 gene was located 5,549 bp
upstream of orfX (Fig. 1) and that the region between ccrAB4
and orfX was identical to that identified between ccrAB4 and
the SCCmec IID remnant in GrMSSA isolates M06/0075.
Determination of location of dcs. Amplification of the region
from dcs to orfX in GrMSSA isolate M04/0269, which yielded dcs
only, identified that dcs was located ca. 1.7-kb upstream of orfX
(Fig. 1).
Investigation of GrMSSA isolates with SCCmec/SCC-associated DNA using real-time PCR rapid MRSA detection assays. Three of the seven GrMSSA isolates with SCCmec/SCC
DNA yielded positive results by both the BD GeneOhm and
Xpert MRSA assays. These included both isolates with ccrAB4
and the SCCmec IID remnant (M06/0075 and M06/0179) and
the one isolate with the region from dcs to orfX (M04/0269).
The remaining four GrMSSA isolates that harbored the
ccrAB4 to orfX region tested negative in both assays.
Clinical details of patients with GrMSSA isolates yielding
amplimers by SCCmec typing PCR. Clinical details of the
patients from whom the five genotype ST8 isolates yielding
SCCmec amplimers were recovered are as follows: M06/0075
and M06/0179 were recovered within 4 months of each other
(M06/0075 was the first of the two isolates to be recovered)
from a 31-year-old male with a 9-year history of chronic
GrMRSA causing osteomyelitis of the left hip; M05/0146
(ccrAB4 only) was cultured from an 82-year-old female with a
fractured femur that was slow to heal; this patient had a
9-month history of GrMRSA; M02/0021 was from a patient for
whom no clinical details were available, but GrMRSA was also
recovered at the same time as the GrMSSA isolate; M04/0269
came from a 7-year-old female with cystic fibrosis from whom
GrMRSA was subsequently isolated (Table 1). AR typing of all
isolates except M06/0179 suggested AR type AR13 or AR14
(the inferred genotype of AR13 and AR14 MRSA is ST8MRSA-II) (59). M06/0179 yielded a pattern that could not be
assigned an AR type because it was susceptible to ampicillin.
The two patients yielding ST5 isolates were resident in longstay care institutions. One patient (M06/0288) had a history of
chronic leg ulcers but no known history of MRSA (Table 1). No
clinical details are available on the other patient (M06/0004). AR
types could not be reliably inferred from the AR pattern obtained
with these isolates. None of the remaining GrMSSA isolates from
patients with a history of MRSA yielded SCCmec typing amplimers, but in each case, MRSA isolates recovered from these
patients were all susceptible to gentamicin (Table 1).
DISCUSSION
A small number of previous studies have identified MSSA
isolates harboring segments of SCCmec-associated DNA, but
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characterization of these segments was limited to DNA sequencing of amplimers obtained by SCCmec typing PCR (e.g.,
ccrAB1, dcs, and IS431-pUB110) or to amplification of a region
usually found downstream of mecA in MRSA (e.g., the SCCmec
right-junction region to orfX and/or the hypervariable region
usually found immediately downstream of mecA to orfX). Details of previous studies are summarized in Table 3. In the
present study, in addition to DNA sequence analysis of the
four SCCmec typing PCR amplimers found in 7 of the 25
GrMSSA isolates investigated (28%), the entire SCCmec remnant in 1 GrMSSA isolate was sequenced. This 26-kb SCCmec
remnant exhibited very high similarity to the type IID SCCmec
element of MRSA, except that regions of the mec complex
structure, including part of mecI and the complete mecR1,
mecA, and IS431 genes, were absent (Fig. 1). The present study
is the first report of such a large SCCmec remnant in MSSA,
and although only part of the class A.4 mec complex was
identified within the remnant (including truncated mecI and
IS1182 genes), this is also the first definitive report of mec
complex genes in MSSA.
The GrMSSA isolates with the SCCmec IID remnant (i.e.,
M06/0075 and M06/0179) appear to be closely related to ST8
MRSA isolates that exhibited variant SCCmec II elements
(IIA [II.3.1.1], IIB [II.3.2.1], IIC [II.3.3.1], IID [II.3.1.2], and
IIE [II.3.3.2]) that were predominant in the Irish nosocomial
MRSA population during the 1990s and continue to constitute
part of the MRSA population in Ireland (59). They share the
same MLST and spa type (ST8/t190), and similar antibiograms.
Comparative sequence analysis of SCCmec IID and the SCCmec
IID remnant identified in the present study revealed that they
are almost identical except that part of the mec complex, including mecA, and a section of the J3 region are not found in
the SCCmec IID remnant (Fig. 1). The patient from whom
isolates M06/0075 and M06/0179 were recovered had a 9-year
history of MRSA prior to culture of these GrMSSA isolates,
suggesting that they may have derived from MRSA by partial
loss of SCCmec. Unfortunately, none of the patient’s MRSA
isolates were available for investigation. Prolonged antibiotic
therapy during the patient’s protracted osteomyelitis infection,
sublethal concentrations of antimicrobials at the site of infection due to poor penetration of antimicrobial agents into bone,
and/or continued survival of the isolate in bone may have
provided suboptimal growth conditions that favored the partial
loss of SCCmec. Other researchers have suggested that MSSA
can arise from MRSA both in vivo and in vitro by a spontaneous loss of mecA (8, 9, 11–13, 17, 23, 33, 43). Loss of mecA has
been reported to occur under stressful conditions in vitro, such
as long-term storage in antibiotic-free medium, nutrient starvation, elevated temperatures, or UV irradiation (17, 27, 49).
In addition, Noto et al. have shown that exposure of MRSA
isolates to vancomycin in vitro can result in a loss of mecA or
portions of SCCmec (43). Daskalaki et al. reported a series of
clonally related isolates recovered from a patient with bacteremia and found evidence that a GrMSSA isolate and a gentamicin-susceptible (GsMRSA) isolate were derived from a
GrMRSA isolate by deletion of mecA and the gentamicin resistance genes aacA-aphD, respectively (8).
Although genotyping showed that 9 CCs were represented
among the 25 GrMSSA isolates investigated in the present
study, the 7 isolates that yielded amplimers by SCCmec typing
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PCR belonged to only 2 CCs, CC8 (n ⫽ 5) and CC5 (n ⫽ 2).
spa typing divided the nine CC8 isolates included in the study
into two clusters; all five ST8 isolates yielding SCCmec typing
PCR amplimers formed one cluster. All patients from whom
these five ST8 isolates were recovered had a history of
GrMRSA, and the AR pattern obtained with four of these five
isolates suggested AR13 (ST8). None of the remaining 20
patients from whom the remaining 20 GrMSSA isolates were
recovered had a history of GrMRSA. The other two GrMSSA
isolates that yielded SCCmec amplimers belonged to CC5
(ST5), and both exhibited the same spa type (t088). Both
isolates came from patients in long-stay care in geographically
remote institutions. Hence, it is unlikely, although possible,
that these isolates are epidemiologically related. However, it is
interesting to note that the spa type t088 is relatively uncommon in the Ridom SpaServer database (frequency, 0.08%).
MRSA with the genotype ST5-MRSA-II have been present in
Ireland since 1989 but never predominated (59). Neither of
these patients had a history of GrMRSA, but one did have
GsMRSA.
In the present study, although three widely used multiplex
SCCmec typing PCR schemes indicated that seven GrMSSA
isolates harbored SCCmec-associated DNA, subsequent amplimer sequencing showed that only three isolates carried
SCCmec-specific DNA (two with the SCCmec IID [II.3.1.2]
remnant and one with the SCCmec-specific dcs region amplimer). All three isolates belonged to ST8, and BURP analysis
of spa typing results placed all three isolates in the same spa
cluster (shown in Table 1). Donnio et al. also reported an ST8
MSSA isolate with the dcs region only, but their isolate had a
different spa type (t008 rather than t3209 as in the present
study) (Table 1) (11). PCR amplification of the dcs to orfx
region of M04/0269 revealed that dcs was located ca. 1.7 kb
upstream of orfX. This is the same location as the dcs to orfX
region in previously described SCCmec elements (59). Further
investigations of isolate M04/0269 are required in order to
identify the extent of SCCmec DNA upstream of dcs in this
GrMSSA isolate. The remaining four GrMSSA isolates yielded
a single amplimer by SCCmec typing PCR, corresponding to
ccrAB4. This ccrAB4 allele was also found in the two isolates
carrying the SCCmec IID (II.3.1.2) remnant and in the 23
MRSA isolates harboring SCCmec II variant elements. In total, ccrAB4 was identified in two distinct genetic backgrounds,
ST8/t190 (MSSA and MRSA) and ST5/t088 (MSSA only).
ccrAB4 shared 100% DNA sequence homology with the
ccrAB4 gene identified in SCC-CI of S. epidermidis ATCC
12228 but was not located within a SCCmec remnant/element. ccrAB4 homologues have been reported previously in
MRSA in SCCmec VI and SCCmecN1, but those ccrAB4
genes share only 91% and 88% similarity, respectively, to
ccrAB4 of SCC-CI in S. epidermidis (14, 48).
SCC-CI is a 57-kb non-mecA-containing SCC element inserted into orfX in the genome of S. epidermidis ATCC 12228
(41). Nested within SCC-CI is a 19-kb SCCpbp4 element,
which harbors ccrAB2 and genes encoding penicillin binding
protein 4 (pbp4) and teichoic acid synthesis (tagF) (41). The
rest of the SCC-CI element, which harbors ccrAB4, lies upstream of the left junction of SCCpbp4. In the present study,
ccrAB4 was located 5,549 bp upstream of the left extremity of
the SCCmec IID remnant/SCCmec element junction in the two
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GrMSSA isolates with the SCCmec IID remnant and in the
same position in the MRSA isolates and 5,549 bp upstream of
orfX in the four GrMSSA isolates with ccrAB4 only. This ca.
5.5-kb DNA sequence exhibited 98.5% sequence identity to
the region located between ccrAB4 and SCCpbp4 in SCC-CI of
S. epidermidis except for the absence of a ca. 1.5-kb region
encoding hypothetical proteins. Further investigations are under way to completely characterize the element(s) harboring
ccrAB4 in these S. aureus isolates, but data from the present
study indicate that ccrAB4 is located on an SCC-CI-like element that lies immediately adjacent to either a SCCmec element/remnant (in MRSA and MSSA) or orfX (in MSSA).
Investigations of the DNA region upstream of ccrAB4 in these
S. aureus isolates will be of particular interest since this region
in SCC-CI harbors genes encoding resistance to cadmium and
mercury and also harbors three IS431 elements. Insertion sequence elements have been reported to promote genomic rearrangements (37), and any additional insertion sequence elements that may be present in these S. aureus isolates may have
played a role in the deletion and rearrangement of regions of
SCC in these isolates.
The identification of DNA in S. aureus with extensive homology to the S. epidermidis SCC-CI element provides further
evidence for horizontal transfer of SCCmec/SCC DNA between S. aureus and coagulase-negative staphylococci (CoNS)
(19, 41, 65). It has been suggested that the direction of transfer
is from CoNS to S. aureus by an as yet unknown mechanism
and that CoNS act as a reservoir for SCCmec/SCC DNA (2, 18,
20, 28, 60, 66). However, it is interesting to note that in the
present study, the ccrAB4 gene with 100% homology to that
found in SCC-CI from S. epidermidis was identified in 29 S.
aureus isolates (23 MRSA isolates and 6 MSSA isolates) belonging to two distinct genetic lineages (ST8/t190 [n ⫽ 27] and
ST5/t088 [n ⫽ 2]), but previous studies have identified this
ccrAB4 gene in only one S. epidermidis strain (41). While this
evidence may suggest that the ccrAB4 gene is more common
among or may even have originated in S. aureus, it may merely
reflect the fact that the majority of previous studies of SCCmec
in S. aureus and CoNS have not involved investigation of
ccrAB4 (19, 20). With the incorporation of detection of ccrAB4
into an SCCmec typing scheme (32) and with the description of
primers specific for ccrAB4 from SCC-CI, it will be interesting
to see the extent to which this ccrAB4 allotype will be detected
in various staphylococcal species in future studies. Further
work involving S. epidermidis isolates and S. aureus isolates
representing the different S. aureus genetic backgrounds from
Ireland and other countries is required to determine the prevalence, significance, and origin of ccrAB4 among S. aureus and
S. epidermidis isolates.
Donnio et al. (11) investigated 247 multiresistant MSSA
isolates from 60 French hospitals using the IDI-MRSA realtime PCR assay to target the right junction region between
SCCmec and orfX and found that 169/247 isolates (68%) were
positive, suggesting carriage of portions of SCCmec. These
isolates belonged to more than 30 spa types, suggesting that
partial loss of SCCmec was not restricted to specific S. aureus
lineages, although isolates with the genotypes ST8 and ST5
predominated. In the present study, SCCmec/SCC-associated
DNA was detected in only 28% of isolates but these isolates
also exhibited either the ST8 or ST5 genotypes (Table 1). It is
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important to highlight the fact that although Donnio et al. (11)
used PCR to detect the ccr genes (ccrAB1, ccrAB2, ccrAB3, and
ccrC), only 2 of the 169 IDI-MRSA assay-positive isolates were
investigated further by PCR amplification of the region downstream of mecA to confirm the presence of SCCmec DNA
sequences. It has been reported that the IDI-MRSA assay is
not specific for SCCmec but also detects SCC sequences (10).
Interestingly, a study of a genetically diverse collection of 42
MSSA isolates mainly from patients with bacteremia or skin
infections or from healthy carriers reported that no isolate was
found to harbor the ccrAB, ccrC, or mecA fragments when
investigated by PCR and Southern hybridization analysis (44).
The presence of SCC- and SCCmec-associated DNA in
MSSA has practical implications for the rapid detection of
MRSA from clinical specimens and for tracking and genotyping of MRSA by SCCmec typing. There are now a number of
commercially available assays that use real-time PCR to detect
SCC-associated sequences directly from clinical specimens for
the rapid detection of MRSA. They include the BD GeneOhm
MRSA assay (10, 25, 51) and Cepheid’s Xpert MRSA assay
(52). During development of the IDI-MRSA assay, the forerunner of the BD GeneOhm MRSA assay, which was the first
FDA-approved commercial system, Huletsky et al. found that
4.6% (26/569) of MSSA isolates investigated were positive,
probably due to the presence of either SCCmec or SCC sequences (25). Another study using the IDI-MRSA assay to
detect MRSA from broth enrichment culture found that 26%
(77/298) of positive specimens carried MSSA (10). In the
present study, the three GrMSSA isolates with SCCmec-specific DNA tested positive with both the BD GeneOhm and
Xpert MRSA assays. Interestingly, Donnio et al. found that
one of the MSSA isolates detected by the IDI-MRSA assay
also harbored the SCCmec dcs region only (11). In contrast,
the four GrMSSA isolates with the SCC-CI-associated ccrAB4
gene tested negative with both assays. These findings suggest
that kit-positive MRSA culture-negative specimens should not
be dismissed lightly as false-positive kit results without taking
the patient’s prior MRSA history into account. The clinical
significance of such positive results in patients with a history of
MRSA is difficult to interpret.
SCCmec typing together with MLST is recommended for
comparison of MRSA strains and is commonly used for routine
epidemiological typing of MRSA (5). The presence of a second
ccr gene (ccrAB4) outside of SCCmec in MRSA isolates could
result in the misinterpretation of typing results for isolates
carrying ccrAB4 in addition to another ccr allotype within
SCCmec, as was found in the present study. When this occurs,
it is important to determine which ccr gene type is part of the
SCCmec element and which is located outside of SCCmec.
In conclusion, this study has found that 28% of GrMSSA
isolates investigated carry remnants of SCC or SCCmec and
that some of these GrMSSA isolates may have been derived
from a previously predominant MRSA clone in Irish hospitals.
The study provides the first detailed description of a 26-kb
SCCmec remnant with ccr and partial mec complex genes in an
MSSA isolate. It is also the first report of S. epidermidis
SCC-CI DNA, including SCC-CI ccrAB4 genes, in MRSA and
MSSA isolates, with a location outside of, but immediately
adjacent to, SCCmec or orfX. The presence of SCCmec-associated DNA in MSSA should be considered when real-time
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PCR assays are used for the rapid detection of MRSA from
clinical specimens. In addition, MRSA isolates with additional
ccr genes located outside of SCCmec may pose problems for
the interpretation of SCCmec typing results.
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